How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| Palo Alto Networks | €306.20 | €301.07 |
| Micron Technology Inc. | €849.70 | €1,300.7 |
| Oracle Corp. | €122.80 | €256.65 |
| Security | Price | Target price |
|---|---|---|
| Lennar Corp. A | €76.66 | €73.20 |
| Southern Copper | €150.35 | €123.05 |
| Campbell Soup Co. | €20.10 | €19.25 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Aerovironment | Piper Sandler | 40.85% |
| B Aerovironment | Stifel Nicolaus | 21.76% |
| B Sparc Ai Inc. | DerAlmanach100000 | 20.53% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Fuelcell Energy Inc. | Vassago1 | -26.58% |
| S Fuelcell Energy Inc. | michaelkr | -24.35% |
| S Astrotech Corp. | michaelkr | -16.67% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
Star depot
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
thyssenkrupp AG
WKN: 750000 / Symbol: TYEKF / Name: thyssenkrupp / Stock / Metals & Mining / Mid Cap /
Pros
Cons
Banca Ifis SpA
WKN: 764940 / Name: Banca IFIS / Stock / Banking Services / Mid Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| Robert Half International | €28.97 | 7.590% |
| Kohl's Corp. | €16.50 | 6.260% |
| Willis Towers Watson plc | €241.70 | 5.950% |
| Universal Health Services B | €140.00 | 5.260% |
| FMC Corp. | €10.10 | 5.160% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Teradyne Inc. | €328.20 | -12.650% |
| KLA-Tencor Corp. | €206.60 | -11.730% |
| Corning Inc. | €173.66 | -10.460% |
| Seagate Technology.Holdings plc | €724.00 | -10.170% |
| Applied Materials Inc. | €515.70 | -9.840% |
Courses
Get started on the stock market in these easy steps
Things you will learn:
- What is a stock
- What is a fund
- What is an ETF
- How to open a depot
- How to manage a depot that will regularly beat managed funds
- Why you mostly need patience to succeed on the stock market
sharewise Introduction
Predictions
Top News
SanDisk’s Volatility May Be Telling Bulls What They Want to Hear
Key Points
- Interested in Sandisk Corporation? Here are five stocks we like better.
- SanDisk shares have swung sharply after a massive AI memory rally, but buyers have repeatedly stepped in after
Meta’s AI Compute Push Could Turn Its Massive CapEx Bill Into a Competitive Weapon
Key Points
- Interested in Meta Platforms, Inc.? Here are five stocks we like better.
- Meta Platforms reportedly plans to sell excess AI compute capacity, a move that could help offset investor
3 Dividend ETFs Built for Stability in a Volatile Market
Key Points
- Interested in ProShares S&P 500 Aristocrats ETF? Here are five stocks we like better.
- Dividend stocks have broadly delivered stable, and in some cases market-beating, returns this year
General Mills Is a 5-Star Turnaround Play for Buy and Hold Investors
Key Points
- Interested in General Mills, Inc.? Here are five stocks we like better.
- General Mills shares appear to have bottomed in early 2026, trading below 10x trailing earnings with a 6.5%
Agility Robotics’ SPAC Deal Opens a Rare Door Into Humanoid AI
Key Points
- Interested in Churchill Capital Corp XI? Here are five stocks we like better.
- Agility Robotics plans to go public through a merger with Churchill Capital Corp XI, creating a rare
Best Forex Robot Performance: How Institutional-Level Automated Trading Is Now Available to Retail MT4 Accounts
Are Options Traders Betting on a Big Move in Ames National Stock?
Investors in Ames National Corporation ATLO need to pay close attention to the stock based on moves in the options market lately. That is because the Oct 16, 2026 $22.50 Call had some of the highest
Can Centene's Integrated Healthcare Model Support Earnings Growth?
Centene Corporation's CNC integrated healthcare model is supporting its earnings potential by combining government-sponsored health plans with coordinated clinical services, pharmacy benefits and
Can AT&T's Build-A-Plan Expansion Strengthen Its Competitive Edge?
AT&T Inc. T is aiming to extend its Build-A-Plan offering to give customers greater flexibility, personalization and value across wireless and home Internet services. The updated offering intends to
Can ExxonMobil's Upstream Business Thrive With Oil Below $70?
Exxon Mobil Corporation XOM has a massive footprint in the Permian, the most prolific oil and gas play in the United States, and offshore Guyana. In the Permian, the integrated giant has been
Tango Therapeutics Rides a New Precision Oncology Trend in 2026
Tango Therapeutics TNGX is becoming a clearer test of how precision oncology can shape biotech value in 2026. Its story now centers on MTAP-deleted cancers, synthetic lethality and targeted
News
Finanzmärkte im Wandel und wie neue digitale Dynamiken Investoren beeinflussen
Payment Rails Are Becoming the New iGaming Growth Story
AtaiBeckley Stock Outlook Depends on Key Pipeline Catalysts in 2026
AtaiBeckley ATAI is entering a catalyst-heavy period as its lead depression program moves closer to late-stage testing. The stock story is tied less to current revenue scale and more to whether its
Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026?
Tango Therapeutics TNGX has become one of 2026’s more dramatic biotechnology stories, with shares up 224.3% year to date and 404.1% over the past year.
That rally reflects real clinical progress
TNGX Stock Outlook Hinges on Vopimetostat and Key 2026 Catalysts
Tango Therapeutics TNGX is moving into a decisive period as vopimetostat becomes the center of the investment case.
The stock story now rests on MTAP-deleted cancers, 2026 clinical updates and the
Vertex Gets FDA Nod for Expanded Use of Casgevy in SCD & TDT
Vertex Pharmaceuticals VRTX announced that the FDA has approved its one-shot gene therapy, Casgevy (exagamglogene autotemcel), for the treatment of individuals aged two years and older with either
Oil Below $70: Buy These 2 Refiners Before the Next Rally
The oil-energy sector continues to be at the top of the major events capturing investors' attention. The market recently witnessed a significant fall in oil prices, thanks to encouraging comments
Netskope Shows How AI Security Is Reshaping SaaS
Netskope NTSK offers a focused view of how cybersecurity demand is changing as enterprises adopt generative artificial intelligence, autonomous agents and cloud-delivered applications.The company is
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobieren
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.